Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Canada has second case of rare blood clots after AstraZeneca vaccine

Published 2021-04-17, 06:54 p/m
Updated 2021-04-17, 07:00 p/m
© Reuters. Arrival of AstraZeneca vaccines in Canada

© Reuters. Arrival of AstraZeneca vaccines in Canada

(Reuters) - Canada on Saturday reported a second case of rare blood clots with low platelets after immunization with AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine in a week, while it said it still recommended the use of the shot.

The person who experienced the very rare event has been treated and is recovering, Canada's health ministry said in a statement, adding that the person lives in the province of Alberta.

Based on the evidence available, Canada still maintains that the benefits of the AstraZeneca vaccine outweigh the potential risks, the statement said.

Canada health authorities "will continue to monitor the use of all COVID-19 vaccines closely and examine and assess any new safety concerns," the statement said.

Canada reported a first blood clotting associated with the vaccine on Tuesday, and a day later, after a review, health authorities said they would not restrict use of the AstraZeneca vaccine.

A separate advisory council had earlier recommended Canada stop offering the vaccine to people under 55. That panel is in the process of reviewing its advice.

Canada has been ramping up its vaccination campaign, but still has a smaller percentage of its population inoculated than dozens of other countries, including the United States and Britain.

© Reuters. Arrival of AstraZeneca vaccines in Canada

Amid a spiking third wave of infections, Ontario, Canada's most populous province, announced new public health restrictions on Friday, including closing the provinces borders to domestic travelers.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.